Evommune Overview
Evommune Target Price
Analysts' 12-month price predictions for EVMN.
Get informed when a big investor buys or sells
+ FollowShare Price
$12.96
Average Target Price
$43.67
236.9% upside
236.9% upside3 analysts in the last 4 months
High: $55 | Low: $26
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-30 | Morgan Stanley | $26 | 100.6% upside |  |
| 2026-05-26 | H.C. WainwrightMitchell Kapoor | $50 | 285.8% upside | |
| 2026-05-11 | Morgan Stanley | $55 | 324.4% upside | |
| 2026-02-18 | Morgan StanleyJudah Frommer | $54 | 316.7% upside | |
| 2026-02-10 | Evercore ISI | $55 | 324.4% upside | |
| 2026-02-10 | H.C. WainwrightMitchell Kapoor | $65 | 401.5% upside | |
| 2026-01-22 | Oppenheimer | $42 | 224.1% upside | |
| 2026-01-07 | Raymond James | $40 | 208.6% upside | |
| 2026-01-06 | H.C. WainwrightMitchell Kapoor | $35 | 170.1% upside | |
| 2025-12-01 | Leerink PartnersThomas Smith | $42 | 224.1% upside | |
| 2025-12-01 | Evercore ISI | $40 | 208.6% upside | |
| 2025-12-01 | Morgan StanleyJudah Frommer | $36 | 177.8% upside | |